Dive into the world of clinical trials from 2024 with us. Our analysis of 10,503 Phase I-III clinical trials reveals a 5.5% growth, with industry-sponsored trials increasing by 3.6%. After a significant downturn in 2022, the clinical landscape experienced a strong recovery in 2023, followed by a more modest one in 2024. The continued growth in 2024 is a clear, positive sign of the sustained rebound that started in 2023. We'll uncover trends across all therapeutic areas, identify key research by disease, and pinpoint the top industry players and geographies that are impacting the industry.